UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Pfizer wins Champix patent suit against 20 local generics makers
by Jeong Sae-im
2019-12-20 16:28
Kolon appeals Invossa’s safety in pleading at court
by Jeong Sae-im
2019-12-20 14:57
4 firms to offer up to 56 direct-to-consumer genetic testing services
by Jeong Sae-im
2019-12-19 16:40
QuantaMatrix passes technology review for Kosdaq listing
by Jeong Sae-im
2019-12-19 14:21
4 new botulinum toxins to undergo trials in crowded market
by Jeong Sae-im
2019-12-18 15:29
라인
Venture capital investment in biomedical sector to hit record this year
by Jeong Sae-im
2019-12-17 14:20
Helixmith to clarify why gene therapy study had data error
by Jeong Sae-im
2019-12-13 15:13
Yuhan to start phase-3 trial on lung cancer drug Lazertinib
by Jeong Sae-im
2019-12-12 15:04
Aprogen, 1st Korean biotech firm to win unicorn status
by Jeong Sae-im
2019-12-11 13:10
Samsung execs get jail term for destroying evidence
by Jeong Sae-im
2019-12-10 11:43
라인
SK Biopharm set to ensure superiority in antiepileptic drug
by Jeong Sae-im
2019-12-04 16:18
Samyang Biopharm’s US subsidiary to work on new immunotherapy
by Jeong Sae-im
2019-12-03 15:37
Alteogen inks licensing-out deal for SC injection formulation technology
by Jeong Sae-im
2019-12-02 15:25
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan
by Jeong Sae-im
2019-11-29 15:23
New Parkinson’s drug Ongentys lands on Korea
by Jeong Sae-im
2019-11-28 14:52
라인
Kolon Life Science’s research head arrested for false Invossa data
by Jeong Sae-im
2019-11-28 11:18
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug
by Jeong Sae-im
2019-11-27 18:24
Roche Diagnostics challenges IBM Watson with differentiated strategy in tailor-made treatment market
by Jeong Sae-im
2019-11-21 15:48
Oncologists vow to fight cancer through precision medicine
by Jeong Sae-im
2019-11-21 14:28
Vivozon’s acquisition of Lumimicro may aim at backdoor listing
by Jeong Sae-im
2019-11-20 14:44
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top